Actions taken at a Chinese cancer hospital may have prevented the spread of SARS-CoV-2 and COVID-19

A scoring system can assess patients’ risk of dying within 90 days of completing concurrent chemoradiotherapy for locally advanced head and neck squamous cell carcinoma

Research sheds light on the risk of neurodegenerative disease after tamoxifen or aromatase inhibitor therapy

Meta-analysis suggests that osimertinib could play a role in the management of intracranial metastases for non-small-cell lung cancer patients with relevant EGFR mutations

Open access: Early data on the transmission of SARS-CoV-2 in Wuhan cancer patients have been published

Patients with non-low-risk breast cancer in situ may experience poorer functional and cosmetic outcomes with use of tumour bed radiotherapy boost during breast-conserving therapy

Bemarituzumab may be a new option for the treatment of fibroblast growth factor receptor (FGFR) 2b-overexpressing advanced gastric and gastro-oesophageal junction adenocarcinoma

Pemigatinib shows second-line activity against locally advanced or metastatic cholangiocarcinoma with fibroblast growth factor receptor 2 gene alterations